Product Details
- Broncast Paediatric Chewable Tablets 4 mg contain montelukast, a leukotriene receptor antagonist used to help control asthma symptoms in children and adults.
- The chewable 4 mg tablets are intended for pediatric use, particularly for infants from 12 months of age and children 2–5 years old, and are also used for adults in the prevention of exercise-induced bronchospasm.
- Broncast helps relieve asthma-related complications such as wheezing, difficulty breathing, chest tightness, and coughing by blocking leukotrienes that cause airway narrowing and swelling.
- Each pack contains 28 chewable tablets, providing a convenient once-daily regimen when used as directed by a healthcare professional.
- The product is stored below 25°C and does not require refrigeration, making it easy to keep at home.
Key Features:
- Active Ingredient Montelukast: Contains montelukast 4 mg, a leukotriene receptor antagonist that helps reduce airway narrowing and swelling associated with asthma.
- Indication for Asthma Control: Used for the management of asthma symptoms and relief of asthma complications in pediatric patients and adults as indicated.
- Exercise-Induced Bronchospasm Prevention: Helps prevent bronchial spasms triggered by physical exercise in adults and children aged 2–5 years and above.
- Pediatric Chewable Formulation: Chewable tablet format is suitable for pediatric use, making administration easier for children who may have difficulty swallowing conventional tablets.
- Once-Daily Dosing: Designed for once-daily use as directed, supporting ongoing control of asthma symptoms.
- Pack Size 28 Tablets: Supplied in a pack of 28 tablets to support continuous daily use over several weeks.
- Storage Conditions: Should be stored below 25°C and not refrigerated, allowing simple room-temperature storage.
- Physician Supervision: Labeled as requiring physician approval, emphasizing use under medical supervision for appropriate monitoring and dosing.
